Conference Agenda
Subject to change, please check back before the event for the most current agenda.
Note: Presentations will be prerecorded and all will be available simultaneously starting at 5:00AM (Pacific) on June 27, 2025.
Virtual Conference | June 27, 2025
Welcome & Opening Remarks
Brian M. Culley, CEO, Lineage Cell Therapeutics
Brian M. Culley, CEO, Lineage Cell Therapeutics
SCI Thought Leader Perspectives
Keynote Address
The SCI Landscape: Decades of Discovery and the Enduring Value of Rehabilitation
Steven Kirshblum, MD – Chief Medical Officer, Kessler Foundation
The SCI Landscape: Decades of Discovery and the Enduring Value of Rehabilitation
Steven Kirshblum, MD – Chief Medical Officer, Kessler Foundation
Perspectives on Neuropathic Pain Following SCI
John (Kip) Kramer, PhD – Asst. Prof., ICORD-Blusson Spinal Cord Centre, University of British Columbia
John (Kip) Kramer, PhD – Asst. Prof., ICORD-Blusson Spinal Cord Centre, University of British Columbia
Perspectives on Spasticity Following SCI
Monica A. Perez, PT, PhD – Scientific Chair & Prof., Shirley Ryan AbilityLab, Northwestern University
Monica A. Perez, PT, PhD – Scientific Chair & Prof., Shirley Ryan AbilityLab, Northwestern University
Current Standards of Care of Rehabilitation (U.S.)
Edelle Field-Fote, PhD – Director of Spinal Cord Injury Research at Shepherd Center
Edelle Field-Fote, PhD – Director of Spinal Cord Injury Research at Shepherd Center
An Overview of SCI Trial Design / NISCI
Armin Curt, MD – Clinical Director, Wings for Life
Armin Curt, MD – Clinical Director, Wings for Life
Subliminal Interference With Recovery After SCI
Jeffrey C. Petruska, PhD – Assoc. Professor, Kentucky SCI Research Center, Univ. of Louisville
Jeffrey C. Petruska, PhD – Assoc. Professor, Kentucky SCI Research Center, Univ. of Louisville
The Structure of the Injured Spinal Cord: How Cells Can Remodel Tissue After Implantation
James Guest, MD, PhD, FACS – Professor, Univ of Miami Miller School of Medicine
James Guest, MD, PhD, FACS – Professor, Univ of Miami Miller School of Medicine
Persons With Lived Experience Sessions
Endpoints and Study Designs in SCI; Opportunities for Developing Novel Interventions
Panelist: Marco Sorani, PhD – Executive Director, Portfolio Strategy & Governance, BeOne Medicines & NorCal SCI Board Member
Moderator: Jack Allen, CFA – Senior Research Analyst, Biotechnology, R.W. Baird & Co., Inc.
Panelist: Marco Sorani, PhD – Executive Director, Portfolio Strategy & Governance, BeOne Medicines & NorCal SCI Board Member
Moderator: Jack Allen, CFA – Senior Research Analyst, Biotechnology, R.W. Baird & Co., Inc.
Personal Perspectives
Panelist: Robert Paylor – Person with Lived Experience & inspirational speaker robertpaylor.com
Moderator: Joseph Pantginis, PhD – Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., LLC
Panelist: Robert Paylor – Person with Lived Experience & inspirational speaker robertpaylor.com
Moderator: Joseph Pantginis, PhD – Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., LLC
Direct and Caregiver Perspectives
Panelists: Jerod & Hanna Nieder – Persons with Lived Experience & Founder of Positively Paralyzed
Moderator: Joseph Pantginis, PhD – Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., LLC
Panelists: Jerod & Hanna Nieder – Persons with Lived Experience & Founder of Positively Paralyzed
Moderator: Joseph Pantginis, PhD – Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., LLC
Clinical Company Presentations
(Listed alphabetically)
Lineage Cell Therapeutics, Inc.
Brian Culley, Chief Executive Officer
Brian Culley, Chief Executive Officer
NervGen Pharma Corp
Michael Kelly, MBA, Chief Executive Officer
Michael Kelly, MBA, Chief Executive Officer
Neuvotion
Chad Bouton, PhD, Founder & Chief Executive Officer
Chad Bouton, PhD, Founder & Chief Executive Officer
NovaGo Therapeutics
Martin Schwab, PhD, Chief Scientific Officer
Martin Schwab, PhD, Chief Scientific Officer
ONWARD Medical N.V.
Dave Marver, Chief Executive Officer
Dave Marver, Chief Executive Officer
Paradromics
Stephen Ryu, MD, Chief Medical Officer
Stephen Ryu, MD, Chief Medical Officer
Synchron
Kurt Haggstrom, Chief Commercial Officer
Kurt Haggstrom, Chief Commercial Officer
Preclinical Company Presentations
(Listed alphabetically)
AmphixBio
Samuel Stupp, PhD, Chief Scientific Officer
Samuel Stupp, PhD, Chief Scientific Officer
Matricelf
Gil Hakim, Chief Executive Officer
Gil Hakim, Chief Executive Officer
Maxonis
Itay Itzhaky, Chief Executive Officer
Itay Itzhaky, Chief Executive Officer
NurExone Biologic Inc.
Lior Shaltiel, PhD, Chief Executive Officer & Director
Lior Shaltiel, PhD, Chief Executive Officer & Director
Spiderwort Biotechnologies, Inc.
Stephen Hanson, PhD, Business Development Director
Stephen Hanson, PhD, Business Development Director
Venture Investors’ Perspectives on Spinal Cord Injury
An Overview of SCIV
Adrien Cohen, MD, Founder, SCI Ventures
Adrien Cohen, MD, Founder, SCI Ventures
Patient Focused Drug Development (PFDD)
An Update on the PFDD Effort
Barry Munro, North American SCI Consortium
Barry Munro, North American SCI Consortium